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H2Bubiquitylation has been implicated in active tran-
scription but is not well understood in mammalian
cells. Beyond earlier identification of hBRE1 as the
E3 ligase for H2B ubiquitylation in human cells, we
now show (1) that hRAD6 serves as the cognate E2-
conjugating enzyme; (2) that hRAD6, through direct
interaction with hPAF-bound hBRE1, is recruited to
transcribed genes and ubiquitylates chromatinized
H2B at lysine 120; (3) that hPAF-mediated transcrip-
tion is required for efficient H2B ubiquitylation as
a result of hPAF-dependent recruitment of hBRE1-
hRAD6 to the Pol II transcription machinery; (4) that
H2B ubiquitylation per se does not affect the level of
hPAF-, SII-, and p300-dependent transcription and
likely functions downstream; and (5) that H2B ubiqui-
tylation directly stimulates hSET1-dependent H3K4
di- and trimethylation. These studies establish the
natural H2B ubiquitylation factors in human cells
and also detail the mechanistic basis for H2B ubiqui-
tylation and function during transcription.
INTRODUCTION
Chromosomal histones are subject to a variety of well-studied
covalent modifications—including acetylation, methylation, and
phosphorylation—that have been implicated in transcriptional
regulation. H2B monoubiquitylation also has been implicated in
transcription by recent genetic and cell-based assays, although
the precise mechanisms involved in H2B ubiquitylation and the
role(s) of ubiquitylated H2B are not fully understood (Weake
and Workman, 2008). Genetic analyses of the highly conserved
RAD6 and BRE1 homologs have suggested that they may func-
tion universally as the relevant ubiquitin-conjugating (E2) and
ubiquitin ligase (E3) enzymes, respectively. However, there arerecent reports that UbcH6 serves as the E2 for H2B ubiquityla-
tion in human cells (Zhu et al., 2005; Pavri et al., 2006).
In contrast to other histone modifications that are concen-
trated in the unstructured N-terminal tails, H2B ubiquitylation
occurs at a residue (lysine 120) that is embedded within the
C-terminal a helix. This may account for the generally low level
of H2B ubiquitylation in cells and suggests an involvement of
additional mechanisms for making the site accessible to H2B
ubiquitylation factors and for target gene specificity. Indeed,
early studies in yeast implicated several transcription factors in
H2B ubiquitylation and indicated a tight linkage between H2B
ubiquitylation and transcription. Thus, RAD6 was shown to be
recruited to the promoter in an activator- and BRE1-dependent
manner and to colocalize with RNA polymerase II (Pol II) depen-
dent upon BRE1 and the PAF complex (Wood et al., 2003; Xiao
et al., 2005), although direct interactions of RAD6 or BRE1 with
Pol II or the PAF complex were not established. Importantly,
requirements of the PAF complex and the Pol II C-terminal
domain (CTD) serine 5 kinase Kin28 for H2B ubiquitylation
have implicated H2B ubiquitylation in transcription elongation
(Ng et al., 2003a; Wood et al., 2003; Xiao et al., 2005). In further
support of this view, defects in H2B ubiquitylation result in sensi-
tivity to 6-azauridine (Xiao et al., 2005) and an altered distribution
of Pol II in gene-coding regions (Tanny et al., 2007).
From a mechanistic viewpoint, H2B ubiquitylation is essential
for specific H3K4 and H3K79 methylation events by Set1
and Dot1, respectively (Dover et al., 2002; Shilatifard, 2006),
but also has H3 methylation-independent functions (Tanny
et al., 2007). In this regard, Pavri et al. (2006) reported that
H2B ubiquitylation directly facilitates FACT-dependent chro-
matin transcription in vitro. Fleming et al. (2008) also reported
a connection between H2B ubiquitylation and FACT during
transcription elongation in vivo but argued for a selective role
for H2B ubiquitylation in chromatin reassembly by FACT
following Pol II passage through a nucleosome. These results
leave open the interesting question of whether H2B ubiquityla-
tion directly stimulates transcription or, conversely, whether
transcription facilitates H2B ubiquitylation for subsequent
functions.Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 459
Figure 1. The N Terminus of hBRE1A Interacts with hBRE1B to Form the hBRE1 Complex
(A) Intracellular interaction of hBRE1A and hBRE1B. 293T cells were transfected with vectors expressing FLAG-hBRE1A and HA-hBRE1B proteins as indicated,
derived cell extracts were incubated with M2 agarose, and bound proteins were visualized by immunoblots with indicated antibodies.
(B) Coomassie blue staining and immunoblot analyses of purified hBRE1 complex with indicated antibodies.
(C) hBRE1Adomains responsible for the hBRE1B interaction. Insect cellswere infectedwith baculoviruses expressing untagged hBRE1Band the indicated FLAG-
hBRE1A fragments, and M2 agarose-purified proteins were visualized by Coomassie blue staining and immunoblots with indicated antibodies (left). A schematic
diagram of hBRE1A and derived fragments, with predicted coiled-coil and RING finger domains, and a summary of the hBRE1 interactions are shown (right).Herewe have employed biochemically defined systems, along
with RNAi analyses, to show that RAD6 is the cognate E2 of the
BRE1 complex and solely responsible for H2B ubiquitylation at
lysine 120 in human cells. We further show that ongoing PAF
complex-dependent transcription is required for efficient H2B
ubiquitylation and that H2B ubiquitylation per se has no discern-
able effect on the level of p300-, PAF complex- and SII-depen-
dent chromatin transcription. Along with further demonstrations
of specific intermolecular interactions between RAD6 and
components of the BRE1 and PAF complexes, these findings
establish the H2B ubiquitylation factors in human cells and
provide a detailed biochemical description of the mechanism
of H2B ubiquitylation and function during transcription.
RESULTS
Human BRE1A Forms a Complex with Human BRE1B
through Its N-terminal Region
Human BRE1A/RNF20 was previously shown to serve as an E3
for H2B ubiquitylation (Kim et al., 2005) and to form a complex
with the hBRE1B/RNF40 paralog (Zhu et al., 2005). In confirma-460 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.tion of an intracellular interaction, ectopically expressed
HA-hBRE1B was coimmunoprecipitated by anti-FLAG antibody
(M2 agarose) only in the presence of FLAG-hBRE1A (Figure 1A).
For more systematic studies, the heteromeric hBRE1 complex
was reconstituted in insect cells by baculovirus-mediated
expression of hBRE1A and FLAG-hBRE1B. The purified complex
contained twopolypeptides (doublet of equal densities) thatwere
individually recognized by anti-hBRE1A and anti-hBRE1B anti-
bodies, thus implying stoichiometric hBRE1A and hBRE1B levels
in the complex (Figure 1B). A further analysis revealed that the
association of hBRE1A with hBRE1B is critically dependent
upon an N-terminal hBRE1A domain (residues 1–381) and further
stabilizedby two central regions (residues 381–517 and 738–872)
that alone show no interaction with hBRE1B (Figure 1C). Overall,
these observations indicate that hBRE1A, through its N-terminal
region, forms a stable stoichiometric complex with hBRE1B.
RAD6 Protein Levels Correlate with H2B Ubiquitylation
and H3K4-H3K79 Methylation Levels in Human Cells
Consistent with the phylogenetic sequence conservation and the
ability of mouse RAD6A and RAD6B to complement yeast Rad6
Figure 2. RAD6 Mediates Endogenous H2B Ubiquitylation and H3K4-H3K79 Methylation in Human Cells
(A) HumanRAD6 can fully complement the function of yeast Rad6 for H2B ubiquitylation andH3K4-H3K79methylation. Yeast whole-cell extracts from awild-type
strain (containing a chromosomal FLAG-H2B gene), its isogenic Drad6 strain, and Drad6 strains that harbor the indicated E2 expression plasmids (driven by the
natural yeast Rad6 promoter) were subjected to immunoblotting with the indicated antibodies. Two different amounts of cell extracts were loaded.
(B) Effects of siRNA-mediated knockdown of H2B ubiquitylation factors on histone modifications. 293T cells were treated with control, hBRE1A, hBRE1B,
hRAD6A, hRAD6B, and hUbcH6 siRNAs indicated. Total cell lysates were subjected to immunoblot analyses with indicated antibodies. A nonspecific band in
the hUbcH6 immunoblot is indicated by an asterisk.
(C) Total RNAs from siRNA-treated cells were subjected to RT-PCR analyses for mRNA levels of indicated genes.(yRad6)mutants for H3K4 dimethylation (Sun and Allis, 2002), we
found that both human RAD6 E2s (hRAD6A and hRAD6B), but
not the hUbcH6 E2, fully complement the function of yRad6 for
H2B ubiquitylation and H3K4-H3K79 di- and trimethylation in
yeast (Figure 2A). These results led us to propose a role for
hRAD6, through an intrinsic E2 activity and in conjunction with
hBRE1, in H2B ubiquitylation in human cells.
In further functional analyses, an hBRE1A siRNA, but not
a control siRNA, resulted in the loss of both hBRE1A (Figure 2B,
first panel, lane 2) and hBRE1B (second panel, lane 2). In
contrast, an hBRE1B siRNA resulted in a large reduction of
hBRE1B (second panel, lane 3) with no effect on hBRE1A (first
panel, lane 3). These data are consistent with the existence of
an hBRE1A$hBRE1B complex (hBRE1 complex) and an associ-
ated stabilization of hBRE1B by hBRE1A. Similarly, hRAD6A and
combined hRAD6A plus hRAD6B siRNAs decreased the level of
hRAD6 (third panel, lanes 5 and 7), whereas an hRAD6B siRNA
did not result in any obvious change in the overall level of
hRAD6 (third panel, lane 6; note that the anti-hRAD6 antibody
does not discriminate hRAD6A and hRAD6B due to their near-
identical amino acid sequences). The latter result is not due to
an inefficiency of hRAD6B siRNA since the hRAD6A and
hRAD6B siRNAs decreased corresponding mRNA levels to
nearly the same extent (Figure 2C). Therefore, consistent with
a previous report (Koken et al., 1996), we conclude that hRAD6Acomprises the majority of the endogenous hRAD6 protein pool.
Finally, an hUbcH6 siRNA effected an almost complete loss of
hUbcH6 protein without causing any changes in the levels of
the other proteins tested (Figure 2B, fourth panel, lane 8).
Reductions of endogenous hBRE1A and hBRE1B, indepen-
dently or together, also resulted in significant concomitant
decreases of H2B ubiquitylation (probed both by an anti-H2B
antibody and by an anti-ubH2B antibody that specifically recog-
nizes ubiquitylated H2B at lysine 120 [Minsky et al., 2008]), H3K4
di- and trimethylation, and H3K79 dimethylation but little or no
changes in H3K4 and H3K79 monomethylation (Figure 2B, lanes
2–4 versus lane 1). Most importantly, hRAD6A siRNA or
combined hRAD6A plus hRAD6B siRNAs resulted in significant
decreases in H2B ubiquitylation and H3K4 trimethylation and
a moderate decrease in H3K79 dimethylation (lanes 5 and 7
versus lane 1). In contrast, but consistent with its negligible effect
on the total hRAD6 level, an hRAD6B siRNA caused no signifi-
cant changes in any of these histonemodifications (lane 6 versus
lane 1). Notably, an almost complete reduction of endogenous
hUbcH6 by an hUbcH6 siRNA failed to effect any detectable
changes in these histone modifications (lane 8). Beyond global
histone modifications, we also observed a clear correlation
between hRAD6 and H2B ubiquitylation levels, as well as H3K4
methylation levels, on the p21 gene (Figure S1 available online).
Taken together, these observations show strong correlationsCell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 461
Figure 3. The hBRE1 Complex Directly and Specifically Interacts with hRAD6A and hRAD6B
(A) Analyses of purified hBRE1 complex, FLAG-hBRE1A, FLAG-hBRE1B, GST, and GST-E2 proteins by Coomassie blue staining. Asterisk, degradation product.
(B) Selective binding of the hBRE1 complex to hRAD6A and hRAD6B. GST pull-down assays employed the purified proteins shown in (A) and bound proteins
were scored by immunoblotting with indicated antibodies.
(C) Intracellular binding of the hBRE1 complex to hRAD6. Total cell lysates from a FLAG-hBRE1A (RNF20) 293T cell line were incubated with M2 agarose, and
bound proteins were visualized by immunoblotting with indicated antibodies.
(D) Analysis of purified His-pK-HA-ubiquitin, FLAG-hE1, and His-E2 proteins by Coomassie blue staining.
(E and F) Ubiquitylation of the hBRE1 complex by hRAD6. The purified hBRE1 complex was analyzed in an E3 ubiquitylation assay with indicated E2 enzymes in
the presence of either 32P-labled (E) or unlabeled (F) ubiquitin, and ubiquitylation of the hBRE1 complex wasmonitored by autoradiography (E) or immunoblot (F),
respectively. Ub 3 2 indicates a ubiquitin dimer.
(G) Binding of the purified hBRE1 complex containing either FLAG-hBRE1A N381 or N230 fragments (Figure 1C) to hRAD6A and hRAD6B.
(H) Schematic of direct binding of the hBRE1 complex to hRAD6.between the level of hRAD6, but not hUbcH6, and the levels of
H2B ubiquitylation and H3K4 and H3K79 methylation.
The Human BRE1 Complex Specifically Interacts
with Human RAD6
Each E3 specifically and directly binds to its cognate E2 (Hershko
andCiechanover, 1998). To identify anE2 thatdirectly binds to the
hBRE1 complex, we examined interactions of the purified hBRE1
complex with several human E2s (Figures 3A and S2A). Among
the nine tested E2s, including hUbcH6, only hRAD6A and
hRAD6B directly bound to the hBRE1 complex (Figures 3B and
S2B). These data contrast with those of an earlier report that
hUbcH6 specifically interacts with the hBRE1 complex (Zhu
et al., 2005). However, the specific physical interaction described462 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.here was also confirmed by other approaches (Figures S3 and
S4). In addition, and importantly, hRAD6 was found to interact
with the hBRE1 complex but not with individual hBRE1A or
hBRE1Bpolypeptides (Figures3BandS3B;Kimet al., 2005), indi-
cating that formationof the heteromeric hBRE1complex is critical
for direct interaction with hRAD6. In a further demonstration of
intracellular interactions (Figure 3C), endogenous hRAD6protein,
but not hUbcH6, was coimmunoprecipitated (by anti-FLAG anti-
body) with hBRE1A and hBRE1B from extracts derived from
human cells that express FLAG-hBRE1A/RNF20. Similar interac-
tions were observed following baculovirus-mediated expression
of hBRE1,hRAD6,andhUbcH6proteins in insect cells (FigureS4).
Direct interactions between RING finger-containing E3
and cognate E2 proteins result in both substrate and E3
ubiquitylation (Lorick et al., 1999). In this regard, and further con-
firming the functional relevance of the physical interaction
between hRAD6 and the hBRE1 complex, incubation of the
hBRE1 complex with purified ubiquitin, E1 and E2 proteins
(Figure 3D) revealed a hRAD6-dependent polyubiquitylation of
the hBRE1 complex that was visualized by autoradiography
(Figure 3E, lanes 2 and 3) and immunoblot (Figure 3F, lanes 2
and 5) and shown to be dependent upon the catalytic activity
of hRAD6 (Figure S5). Although purified hUbcH6 exhibited
a strong ubiquitin-conjugating activity, it failed to mediate any
detectable polyubiquitylation of the hBRE1 complex (Fig-
ure 3E, lane 4; Figure 3F, lanes 3 and 6; Figure S5B).
Several reports showed that the signature RING finger
domains of E3s serve as platforms for the E2 binding that is
essential for protein ubiquitylation (Lorick et al., 1999). Surpris-
ingly, we found that the C-terminal RING fingers in hBRE1A
and hBRE1B are both dispensable for ubiquitylation of the
hBRE1 complex (Figure S6), suggesting that hRAD6 interacts
with the hBRE1 complex through a region(s) other than the
RING finger domain. As expected from the results of
Figure 3B, an hBRE1 complex containing intact hBRE1B and
theminimal hBRE1A fragment (N381) capable of complex forma-
tion with hBRE1B (Figure 1C) was shown to interact with hRAD6
whereas hBRE1B and an hBRE1A fragment (N230) that is unable
to form a complex with hBRE1B could not (Figure 3G). These
results demonstrate unequivocally that hRAD6, but not hUbcH6,
interacts specifically and functionally with the hBRE1 complex,
both in vitro and in vivo, through a region other than the RING
finger domain in the hBRE1 complex (Figure 3H; see Discussion).
Human RAD6 Ubiquitylates Chromatin-Associated H2B
at Lysine 120 Only in the Presence of the Human BRE1
Complex
To clearly demonstrate a direct hRAD6 E2 function in H2B ubiq-
uitylation, we employed an in vitro chromatin ubiquitylation
assay. Complete reactions containing purified E1, hRAD6A, the
hBRE1 complex, ubiquitin (His- and HA-tagged), and oligonu-
cleosomes derived from HeLa cells generated a lysine 120-ubiq-
uitylated H2B (ubH2B) (Figure 4A, top panel, lanes 2 and 8),
whereas reactions with omission of any of these components
did not (top panel, lanes 3–7). Although a significant level of
H2B ubiquitylation was detected in the absence of the hBRE1
complex, this clearly represents H2B ubiquitylation at a site(s)
other than lysine 120 (compare top panel, lane 5 versus middle
panel, lane 5). This is consistent with the ability of RAD6 to ubiq-
uitylate free core histones (Jentsch et al., 1987; Figure S7),
as well as both histone octamer and nucleosomal substrates
(Figure S7), in the absence of an E3. This appears to reflect
a nonspecific RAD6 ubiquitin-conjugating activity that is
manifested in a purified assay system lacking constraints that
normally control accessibility of RAD6 to histones. These results
also strengthen the validity of the anti-ubH2B antibody for moni-
toring precise in vitro H2B ubiquitylation events.
In relation to specificity and possible redundancy of the ubiq-
uitylation enzymes, hRAD6A (more efficiently) and hRAD6B (less
efficiently) were both found to ubiquitylate H2B at lysine 120 in
a catalytic activity-dependent manner (Figure 4B, lanes 1–5).
Notably, hUbcH6 failed to generate any detectable ubH2B (lanes6–8), even at a 3-fold higher dose than hRAD6 (lane 8). Unlike
individual RAD6 proteins, individual hBRE1A and hBRE1B poly-
peptides failed tomediate ubiquitylation of H2B (Figure 4C, lanes
1–4), thus demonstrating that formation of the heteromeric BRE1
complex and the resulting interaction with RAD6 are critical for
the E3 function of the hBRE1s. In a further analysis of purified
hBRE1 complexes with combinations of RING finger deletions
(Figure S6), H2B ubiquitylation was abrogated by deletion either
of both RING fingers (Figure 4C, lane 7 versus lane 4) or of the
hBRE1A RING finger (lane 5 versus lane 4) but was relatively
unaffected by deletion of the hBRE1B RING finger (lane 6 versus
lane 4). Overall these results indicate redundant functions for
RAD6A and RAD6B, but distinct functions for the essential
hBRE1A and hBRE1B proteins (and their individual RING
fingers), in H2B ubiquitylation (see Discussion).
In a further analysis of the efficiency of the in vitro H2B ubiqui-
tylation reactions, we observed a dose-dependent increase in
H2B ubiquitylation in response to varying amounts of the
hBRE1 complex (Figure 4D, lanes 2–4), but not of hRAD6A (lanes
5–7). These data suggest that the hBRE1 complex is more
limiting for H2B ubiquitylation, at least in vitro, and may explain
enhanced H2B ubiquitylation by ectopic hBRE1A, but not by
ectopic hRAD6, in a cell-based assay (Kim et al., 2005).
RAD6 Association with the PAF Complex Is Dependent
upon the BRE1 Complex, which Interacts Directly
with the PAF Complex through the PAF1 Subunit
The PAF elongation factor complex is required for both H2B
ubiquitylation and H3K4-K79 methylation in yeast (Krogan
et al., 2003; Ng et al., 2003a; Wood et al., 2003; Xiao et al.,
2005). To test how the human PAF (hPAF) complex links H2B
ubiquitylation and transcription processes, we first examined
the interaction between highly purified E2 proteins (Figure 3A)
and hBRE1 and hPAF complexes (Figure 5A). Interestingly,
hRAD6A and hRAD6B were shown to associate with the purified
hPAF complex in the presence, but not in the absence, of the
hBRE1 complex (Figure 5B, lanes 7 and 8 versus lanes 3 and
4). Given the earlier demonstration of direct hRAD6-hBRE1
complex interactions (above), these results suggest that the
hBRE1 complex mediates the association of hRAD6 with the
hPAF complex. In confirmation, the purified hBRE1 complex
was found to bind directly to the purified hPAF complex
(Figure 5C). A further analysis with individual subunits of the
hPAF complex (Figure 5D) showed a strong selective binding
of the purified hBRE1 complex to the hPAF1 subunit
(Figure 5E), thus implicating hPAF1 as the major subunit respon-
sible for interaction of the hPAF complex with the hBRE1
complex. Although hUbcH6 was shown to interact weakly
(potentially nonspecifically; below), with the hPAF complex,
inclusion of the hBRE1 complex in the reaction did not alter
binding efficiency (Figure 5B, lane 5 versus lane 9).
In view of the direct association of the hRAD6-hBRE1 complex
with the hPAF complex, we tested whether the hPAF complex
directly stimulates H2B ubiquitylation. Somewhat surprisingly,
the hPAF complex was found to decrease hRAD6-hBRE1
complex-mediated H2B ubiquitylation within an oligonucleo-
some substrate (Figure 5F, lanes 3–5 versus lane 2), presumably
because a strong competitive binding of the hPAF complex inCell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 463
Figure 4. RAD6 Is the E2 Ubiquitin-Conjugating Enzyme for H2B Lysine 120 Ubiquitylation in Human Cells
In vitro chromatin ubiquitylation assays. Reactions containing 5 mg oligonucleosome, 100 ng hE1, 200 ng E2, 600 ng hBRE1 complex, and 2.8 mg
His-pK-HA-tagged ubiquitin, unless otherwise indicated, were subjected to immunoblot with antibodies indicated on the left of each panel.
(A) Collective requirement of factors for H2B ubiquitylation. Note that endogenous ubiquitylated H2B (in the oligonucleosome substrate) is not detectable by
anti-H2B antibody (middle panel).
(B) Comparison of hRAD6 and hUbcH6 E2 activities for H2B ubiquitylation. Reactions contained 200 ngwild-type ormutant hRAD6 (lanes 2–5) and 100 ng (lane 6),
200 ng (lane 7), or 600 ng (lane 8) hUbcH6.
(C) hBRE1 complex RING finger requirement for H2B ubiquitylation. FLAG-hBRE1A, FLAG-hBRE1B, and hBRE1 complexes (isolated via FLAG-hBRE1A) with
intact or deleted (either or both) RING fingers are indicated.
(D) The hBRE1 complex is limiting for H2B ubiquitylation. Reactions contained 50 ng (lane 2), 150 ng (lane 3), or 450 ng (lane 4) hBRE1 complex and 50 ng (lane 5),
100 ng (lane 6), or 200 ng (lane 7) hRAD6A.this context prevents the hBRE1 complex from binding effec-
tively to histones. This suggests that the PAF complex plays
a role in H2B ubiquitylation other than stimulating catalysis by
RAD6-BRE1. Consistent with our inability to see any role for
hUbcH6 in H2B ubiquitylation, hUbcH6 still did not effect any
detectable H2B ubiquitylation in our assays even in the presence
of the hPAF complex (Figure 5F, lanes 6–9).
The PAF Complex Plays a Role in H2B Ubiquitylation
within Chromatin Templates through an Effect
on Transcription
In order to test the role of the PAF complex in H2B ubiquitylation
during transcription, we employed an in vitro assay (schematized
in Figure 6A) containing purified factors and a chromatinized
pML array template that contains p53-binding sites (Figure S8).
An assay under transcription conditions with all components
present generated a very significant level of H2B ubiquitylation
at lysine 120 (Figure 6B, compare lanes 3 and 9). This corre-464 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.sponds to ubiquitylation of about 15% of the total H2B used
for transcription, as judged by comparison with histone octamer
standards (compare lane 3 versus lanes 10–14) containing fully
ubiquitylated H2B (McGinty et al., 2008). We also confirmed
a requirement for the hBRE1 complex (Figure 6B, lane 4) and
an inability of hUbcH6 to substitute for the E2 function of
hRAD6 (lane 8). Importantly, this efficient H2B ubiquitylation is
coupled to activator-dependent transcription because omission
of either p53 or nucleoside triphosphates (but with ATP present)
reduced ubH2B to an undetectable level (lanes 1 and 2). Simi-
larly, omission of the hPAF complex resulted in an undetectable
level of ubH2B (lanes 5 and 7) whereas SII omission significantly
decreased the efficiency of H2B ubiquitylation (lane 6). As shown
in Figure 6D, and as will be detailed elsewhere (J.K., M.G., and
R.G.R., unpublished data), SII and the hPAF complex act inde-
pendently to effect equivalent low levels of transcription, and
synergistically to effect high levels of transcription, in this assay
(lanes 1–4). Hence, the efficiency of H2B ubiquitylation generally
Figure 5. The hPAF Complex Directly Interacts with the hBRE1 Complex
(A and D) Analyses of purified proteins by Coomassie blue staining. Reconstituted hPAF (isolated via FLAG-hPAF1) and hBRE1 (isolated via His-hBRE1B)
complexes (A) and individual FLAG-tagged subunits of the hPAF complex (D) were expressed from baculovirus vectors. Asterisk, nonspecific bands.
(B, C, and E) Binding of the purified hPAF complex or isolated subunits to H2B ubiquitylation factors. The purified hPAF complex was tested for binding to
GST-fused E2 proteins in the presence and in the absence of the hBRE1 complex (B). The purified hBRE1 complex was tested for binding to the M2
agarose-immobilized hPAF complex (C) or to individual hPAF complex subunits (E). Bound proteins were scored by immunoblot with indicated antibodies.
(F) Effect of the hPAF complex on H2B ubiquitylation. The chromatin ubiquitylation assay was performed as in Figure 4. Reactions contained 150 ng (lanes 3
and 7), 300 ng (lanes 4 and 8), or 600 ng (lanes 5 and 9) hPAF complex and hRAD6A or hUbcH6 additions as indicated.correlates with the transcription level. These results thus suggest
that the PAF complex facilitates H2B ubiquitylation through an
effect on transcription and thereby directly links transcription
to H2B ubiquitylation factors (Figure 6C). However, the fact
that omission of the hPAF complex completely eliminates H2B
ubiquitylation, while omission of SII does not, indicates that
H2B ubiquitylation is also dependent upon hPAF complex func-
tions other than those directly connected to transcription.
Effect of H2B Ubiquitylation on Chromatin Transcription
and H3K4 Methylation
We next tested the effect of H2B ubiquitylation on hPAF- and
SII-dependent transcription of chromatin by p53. Surprisingly,
we found that addition of ubiquitylation factors (ubiquitin, E1,
hRAD6A, and the hBRE1 complex) actually effected a moderate
decrease in transcription (Figure 6D, lanes 2, 3, and 4 versus
lanes 6, 7, and 8). However, this inhibition is not due to H2B ubiq-
uitylation at lysine 120 since these inhibitory effects were also
observed in transcription of chromatin reconstituted with the
H2B K120R mutant (lanes 10, 11, and 12 versus lanes 14, 15,
and 16). In a test for contributions of individual factors to the
inhibitory effect (Figure 6E), we found transcription inhibition
mainly in reactions containing hRAD6A (lanes 2 and 13 versus
lanes 3, 5, 8, 10, 11, and 12). We suspect that this modest
nonspecific hRAD6-dependent transcription inhibition is due
both to a lack of normal constraints to interfering interactions(such as nonspecific binding of hRAD6 to histones; Figure S7)
and to a lack of positively acting effectors that recognize
ubH2B in the purified assay system. In addition, hUbcH6 alone
(lane 15) or with other ubiquitylation factors (lane 16) did not
increase, but instead slightly decreased, transcription.
To testmoredirectly for an effect ofH2Bubiquitylation onchro-
matin transcription in the absence of the chromatin ubiquitylation
machinery, we assembled chromatin with histone octamers con-
taining a semisynthetic H2B fully ubiquitylated at lysine 120
(McGinty et al., 2008; Figure S9). Interestingly, chromatin
templates assembled with intact H2B versus ubH2B octamers
showedsimilarmicrococcal nuclease (MNase) digestionpatterns
(Figure S9), indicating that the bulky ubiquitin adduct does not
alter overall recombinant chromatin structure.More interestingly,
in a test for effects of ubH2B on transcription of chromatin (Fig-
ure 6F), the level of basal (coactivator-independent) transcription
and the levels of hPAF complex- and SII-dependent transcription
from completely H2B-ubiquitylated chromatin were indistin-
guishable from those observed with unmodified chromatin (lane
2 versus lanes 6 and 10; lane 3 versus lanes 7 and 11; lane 4
versus lanes 8 and 12). Thus, ubH2B itself does not result in
any structural changes that noticeably affect either the repressed
state of the reconstitutedchromatin or its activationby the factors
in our defined assay system (see Discussion).
Our observation that H2B ubiquitylation is both transcription
dependent and unable alone to directly affect transcriptionCell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 465
Figure 6. Transcription-Dependent H2B Ubiquitylation
(A) Schematic representation of the standard in vitro transcription assay. Transcription factors included TFIIA, TFIIB, TFIIE, TFIID, TFIIF, TFIIH, PC4,Mediator, and
Pol II. Ubiquitylation factors included E1, E2 (hRAD6A or hUbcH6), the hBRE1 complex, and ubiquitin. Chromatin-based assays also contained the components
(ACF1, ISWI, NAP1, and TOPO1) employed for chromatin assembly. Reactions contained 10 ng p53, 20 ng p300, 240 ng hPAF complex, 10 ng SII, 25 ng E1, 25 ng
E2, 75 ng hBRE1 complex, and 350 ng ubiquitin where indicated.
(B) Transcription-coupledH2Bubiquitylation assayswith deletions and additions as indicated (lanes 1–9). In each case, nine standard transcription reactionswere
combined, concentrated, and subjected to immunoblotswith indicated antibodies. Note that all four unmodified nucleoside triphosphateswere used in this assay.
Histone octamers containing fully ubiquitylated H2B (indicated as % of histone octamers present in the transcription assay) were loaded in lanes 10–14.
(C) Schematic model of transcription-coupled H2B ubiquitylation. Verified direct interactions are depicted by red lines.
(D–F) Effects of H2B ubiquitylation factors (D and E) or fully ubiquitylated (semisynthetic) H2B (F) on chromatin transcription. Relative transcription levels were
quantitated by phosphoimager and normalized to that of SII alone (D and F) or to that of the hPAF complex and SII (E).
(G and H) H2B ubiquitylation directly stimulates hSET1 complex-mediated H3K4 di- and trimethylation. (G) Analyses of purified hSET1 complex (isolated via
FLAG-hCFP1 by M2 agarose from a stable FLAG-hCFP1 cell line) by immunoblot. (H) Chromatin templates were assembled with unmodified H2B (lane 1) or
ubH2B (lane 2) octamers and subjected to in vitro methylation assay with purified hSET1 complex. H3 methylation status was probed by indicated antibodies.
The fast migrating band (asterisk) detected by an anti-H3 antibody in lane 2 is thought be N-terminus-deleted H3 because this band is not detected by H3K4
modification-specific antibodies.466 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.
Figure 7. Distribution of the H2B Ubiquitylation Factors and Ubiquitylated H2B on the p21 Locus during p53-Dependent Transcription
(A) Doxorubicin induction of p53 and the p21 target gene. HCT116 cells were treated with 0.5 mM doxorubicin for the indicated times, and proteins and mRNA
levels were analyzed by immunoblot and RT-PCR, respectively.
(B) Schematic representation of the p21 locus indicating six amplicons used for real-time PCR.
(C) ChIP analyses on the p21 locus. Cells were treated as in (A) and ChIP analyses were performed with indicated antibodies. Error bars denote standard
deviations from three independent PCR reactions from a single ChIP that is representative of several that were performed. (Note: these data are part of a compre-
hensive ChIP analysis and limited parts [e.g., p53 and p21 expression data and p53 and Pol II ChIP data] are expected to be published, for cross-reference, with
more extensive data on SII and individual hPAF complex subunit analyses.)throughchromatinsuggests thatubH2Bmustaffectadownstream
factor(s) that in turn influences transcription. To test a potential role
for ubH2B in directly facilitating H3K4 methylation by SET1, the
hSET1 complex was purified from HeLa cells that stably express
a FLAG-tagged subunit (hCFP1) unique to the hSET1methyltrans-
ferase complex. The composition of the isolated complex was
similar to that reported by Lee and Skalnik (2005), using the
same approach, and the immunoblot in Figure 6G confirms
the presence of established subunits (including hSET1) of this
complex. The hSET1 complex exhibits efficient H3K4 monome-
thylation activity on both unmodified and H2B-ubiquitylated
chromatins (Figure 6H). Remarkably, however, the presence of
ubH2B on chromatin significantly stimulates hSET1 complex-
dependent H3K4 di- and trimethylation (lane 2 versus lane 1).
Taken together, these data strongly suggest that transcription-
coupledH2Bubiquitylationdirectly stimulatesH3K4di- and trime-thylation by the hSET1 complex and thus explain why H2B ubiqui-
tylation is concentrated on actively transcribing genes (Minsky
et al., 2008) and why H2B ubiquitylation-dependent H3K4 trime-
thylation marks recent transcription events (Ng et al., 2003b).
Distribution of H2B Ubiquitylation Factors
and Ubiquitylated H2B on Endogenous
Genes during Transcription Activation
Given our previous demonstration of physical and functional
interactions of p53 and hBRE1 (Kim et al., 2005), the p53-depen-
dent doxorubicin-inducible p21 gene was chosen for analysis by
chromatin immunoprecipitation (ChIP) of the region-specific
accumulation of ubH2B and related factors during gene activa-
tion. Following verification of the expected doxorubicin-depen-
dent increases in levels of p53 and p21 proteins and transcripts
(Figure 7A), six regions of the p21 locus were probed withCell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 467
corresponding amplicons (summarized in Figure 7B). Consistent
with previous studies by others, we observed (1) a basal level of
p53 at RE1 (region labeled ‘‘A’’ in Figure 7B) and RE2 (B) regions,
followed by continuous doxorubicin-induced increases in p53
occupancy only at these sites over a 12 hr period; (2) a basal level
of paused Pol II at the promoter region (C) followed by time-
dependent increases both at the promoter (C) and (at reduced
levels) along the coding regions (D, E, and F) in response to
doxorubicin, the latter representing movement of Pol II toward
the 30 region during the transcription process.
As will also be reported elsewhere in conjunction with an
analysis of SII and all hPAF complex subunits (J.K., M.G., and
R.G.R., unpublished data), hPAF1 occupancy at the promoter
region (C) was not significant at the uninduced (0 hr) stage but
was increased at the promoter (C) and, especially, the adjacent
(D) and downstream (E and F) transcribed regions in response
to doxorubicin. This suggests that Pol II-mediated recruitment
(or subsequent stabilization) of the hPAFcomplex at thepromoter
and downstream regions is tightly regulated by ongoing tran-
scription. In addition, the higher levels of hPAF1 accumulation
at transcribed regions (D, E, andF), relative to thepromoter region
(C), are consistent with the proposed function of the hPAF
complexasa transcriptionelongation factor. ThehBRE1Apattern
wassomewhat similar to thatobserved for hPAF1, consistentwith
hPAF complex-dependent recruitment of the hBRE1 complex to
the chromatin, butwith the exception of an obvious accumulation
at RE1, RE2, and promoter regions. The latter result may reflect
the hBRE1 potential for direct interactions with p53 (Kim et al.,
2005; Figure S10). Interestingly, hE1 showed an increased accu-
mulation, beyond a high basal level, at all tested regions upon
gene activation. This might reflect the universal requirement of
E1 for all other ubiquitylation reactions (beyond H2B ubiquityla-
tion), as shown for a proteasome complex that is recruited to
the genes after activation (Gonzalez et al., 2002). hRAD6 recruit-
ment showed a broad increase over a 12 hr period, with the high-
est level at the 50 transcribed region (D) and a pattern somewhat
similar to that observed for hBRE1A. This may reflect hBRE1-
and hPAF complex-dependent recruitment of hRAD6. However,
RAD6 accumulation may also reflect other pathways since
RAD6 serves as the E2 for ubiquitylation of proteins other than
H2B and, related, since DNA damage induces localization of
RAD6 and its cognate E3 RAD18 to chromatin (Lyakhovich and
Shekhar, 2004). Importantly, although hUbcH6 showed a broad
distribution across the p21 gene in the uninduced state, as well
as aweak interactionwith the hPAFcomplex (Figure 5B), the level
of associated hUbcH6 actually decreased upon doxorubicin-
induced transcription of the p21 gene.
Analyses of p21-associated ubH2B (normalized to total H2B
levels) revealed significant levels of ubH2B at both promoter
(C) and transcribed (D, E, and F) regions, which were increased
following p21 induction. Importantly, the level of ubH2B was
highest at the middle coding region (E) and considerably lower
at the 30 coding region, consistent with a recent report (Minsky
et al., 2008). The lower level of ubH2B at the 50 transcribed region
(D) relative to the middle coding region (E), despite higher levels
of H2B ubiquitylation factors at the D region than at the E region,
may be related to the preferential recruitment and action of an
H2B deubiquitylation factor at the early transcribed region468 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.(Zhang et al., 2008). It also is noteworthy that whereas significant
amounts of H2B ubiquitylation factors are present in untran-
scribed (A and B) regions, ubH2B is concentrated in the
transcribed regions. This supports the notion that efficient H2B
ubiquitylation (or stabilization) is coupled to transcription events.
DISCUSSION
The increasingly appreciated roles of H2B ubiquitylation in
diverse transcription events must ultimately be understood at
a mechanistic level, necessitating both biochemical and genetic
analyses with properly defined (physiological) components of
the ubiquitylation machinery. Here, our elucidation of the factors
essential for robust H2B K120 ubiquitylation in human cells and
their deployment in biochemically defined chromatin-templated
assays have revealed significant mechanistic aspects of H2B
ubiquitylation during transcription. Our results show (1) that
RAD6 is the cognate E2 for the hBRE1 E3 complex and solely
responsible for H2B ubiquitylation in human cells; (2) that the
hPAF complex is required for efficient H2B ubiquitylation
and acts by recruiting the H2B ubiquitylation machinery to the
transcription machinery, through direct interactions with the
hBRE1 complex and with RNA polymerase II, and not by directly
stimulating RAD6-BRE1 catalytic activity; (3) importantly, that
ongoing transcription is required for efficient H2B ubiquitylation;
(4) that, despite its bulk, ubH2B itself does not affect hPAF
complex- and SII-mediated chromatin transcription directly,
consistent with a downstream function; and, related, (v) that
ubH2B can directly enhance H3K4 di- and trimethylation by
the hSET1 complex. By identifying the essential factors for
robust H2B ubiquitylation in human cells and by elaborating
the mechanistic basis for H2B ubiquitylation, these results
provide insights into the complex mechanism of H2B ubiquityla-
tion during transcription.
The BRE1 Complex as a Functional E3 Ubiquitin Ligase
for H2B Ubiquitylation
In an extension of earlier work (Kim et al., 2005; Zhu et al., 2005),
functional studies have shown that the human BRE1A and
BRE1B paralogs are both required for H2B ubiquitylation
in vivo and in vitro. Additional studies indicated that the RING
finger-type hBRE1A and hBRE1B E3s interact through an
N-terminal region of hBRE1A and that complex formation is
important for stability of individual components (notably
hBRE1B). Given recent demonstrations of a heteromeric
complex between the two essential BRE1 paralogs in fission
yeast (Tanny et al., 2007) and a multimeric complex of the single
Bre1 in budding yeast (Figure S11), it is likely that the formation of
a multimeric BRE1 complex is conserved from yeast to human
and is essential for its E3 function.
Although hBRE1A and hBRE1B are both required for H2B
ubiquitylation, the hBRE1A RING finger is critical whereas the
hBRE1B RING finger is dispensable. Thus, despite similar
structures, the two hBRE1 homologs play distinct roles in H2B
ubiquitylation. In addition, the fact that hRAD6 binds to the
hBRE1 complex but not to hBRE1A or hBRE1B alone may
explain in part why hBRE1B, but not its RING finger, is required
for H2B ubiquitylation.
Identification of RAD6 as the E2 Ubiquitin-Conjugating
Enzyme for H2B Ubiquitylation in Human Cells
Consistent with expectations from the phylogenetic conserva-
tion of the RAD6 protein and from genetic studies in several
organisms (reviewed in Weake and Workman, 2008), but in
contrast to reports of a role for the human UbcH6 E2 (Zhu
et al., 2005; Pavri et al., 2006), our current studies provide
unequivocal evidence that RAD6 functions as the physiological
E2 for H2B ubiquitylation in human cells. First, hRAD6 protein
levels correlate with both global and gene-specific H2B ubiquity-
lation in RNAi analyses. Second, hRAD6 directly interacts with
the hBRE1 complex via a specific domain. Third, hRAD6 exhibits
an E2 activity for robust H2B ubiquitylation at lysine 120 both in
pure assays with natural oligonucleosome substrates and in
transcription-coupled assays with recombinant chromatin
templates. Fourth, ChIP analyses show that hRAD6 is actively
recruited to a transcribed gene upon gene induction. Since
none of these parameters were evident for UbcH6, its role in
the cell may be restricted to a minor H2B, or more likely to
a distinct, ubiquitylation pathway.
The strong homology (over 95% similarity) between hRAD6A
and hRAD6B is suggestive of redundant functions. Although
a concomitant decrease in H2B ubiquitylation and total RAD6
protein was only observed with hRAD6A siRNA, and not with
hRAD6B siRNA, this reflects the fact that hRAD6A is much
more abundant than hRAD6B in cells (Koken et al., 1996). In
addition, our in vitro assays with chromatin substrates clearly
showed that hRAD6A and hRAD6B both have the ability to ubiq-
uitylate H2B. Therefore, our results suggest that the normal H2B
ubiquitylation observed in RAD6B knockout mice (Baarends
et al., 2007) is due to the redundant function of intact RAD6A.
For some E3s, target protein ubiquitylation involves direct
interaction of a resident RING finger with the corresponding E2
(Lorick et al., 1999). However, the Ubr1 N-end rule E3 (Xie and
Varshavsky, 1999) and the DNA repair-related RAD18-RAD5
E3 (Ulrich and Jentsch, 2000) interact with their cognate E2,
RAD6, in a RING finger-independent manner. We also found
that the BRE1 complex interacts with RAD6 in a RING finger-
independent manner both in human (Figure 3) and in yeast
(J.K. and R.G.R., unpublished data). The fact that RAD6 is the
cognate E2 for these E3s indicates that RAD6 is a noncanonical
E2 that binds to its cognate E3 via regions other than the RING
finger and further suggests that the role of the RING finger in
E3 is not merely to recruit E2 to the vicinity of the target proteins.
Mechanistic View of the Role of the PAF Complex
in H2B Ubiquitylation
The PAF complex requirement for both H2B ubiquitylation and
downstream H3K4 and H3K79 methylation has been well-docu-
mented by yeast genetics (Krogan et al., 2003; Ng et al., 2003a;
Wood et al., 2003; Xiao et al., 2005). However, there has been no
clear biochemical evidence that explains the direct role of the
PAF complex in H2B ubiquitylation. In the present study, our
chromatin-templated ubiquitylation and transcription assays
with defined factors have revealed distinct PAF complex func-
tions in H2B ubiquitylation. First, the PAF complex can recruit
H2B ubiquitylation factors to chromatin through direct interac-
tions with both the BRE1 complex and Pol II. Second, the PAFcomplex couples transcription and efficient H2B ubiquitylation
through its intrinsic chromatin transcription enabling activity
rather than through a direct stimulation of RAD6-BRE1 activity.
It is plausible that the PAF complex-enhanced passage of Pol
II through nucleosomes allows H2B ubiquitylation factors (re-
cruited by the PAF complex) easier access to the H2B ubiquity-
lation site. The fact that H2B ubiquitylation is further enhanced by
SII, which synergistically increases transcription with the hPAF
complex, strengthens our claim that efficient H2B ubiquitylation
is coupled to transcription. This relationship (hRAD6/hBRE1
complex/hPAF complex/Pol II) nicely fits the yeast genetic
data wherein yBre1 deletion completely abrogates yRad6 asso-
ciation with the entire body of Pol II-dependent genes (Wood
et al., 2003; Xiao et al., 2005) and wherein deletion of the PAF
complex subunit yRtf1 leads to dissociation of yRad6 from
coding regions (Xiao et al., 2005). Along with these observations,
our data contrast with a previous report (Zhu et al., 2005) that
hUbcH6, rather than the hBRE1 complex, interacts with the
hPAF complex to physically link the H2B ubiquitylation
machinery to Pol II and that the hPAF complex enhances
hUbcH6-mediated H2B ubiquitylation in the absence of ongoing
transcription.
Role of Histone H2B Ubiquitylation in Transcription
and H3 Methylation
Cell-based assays have shown that H2B ubiquitylation is
required for proper activation of several inducible genes and,
conversely, that a number of factors implicated in transcription
initiation and elongation are required for H2B ubiquitylation
(Weake and Workman, 2008). An intriguing question raised by
these results is whether H2B ubiquitylation itself stimulates
transcription or whether transcription facilitates H2B ubiquityla-
tion for purpose of a subsequent ubiquitylated H2B function.
Relevant to this issue, our transcription-coupled chromatin ubiq-
uitylation assays with biochemically defined factors clearly show
that ongoing transcription is required for efficient H2B ubiquity-
lation (Figure 6B). Of note, the overall level of H2B ubiquitylation
in this assay (about 15%) is markedly higher than the level (<1%)
observed with oligonucleosome substrates in the absence
of transcription. Moreover, since only a small portion of the
chromatin template is transcribed in vitro, the level of H2B ubiq-
uitylation may be much greater than 15% in the transcribed
region. In addition, our demonstration of low-level transcrip-
tion-independent H2B ubiquitylation with natural HeLa cell-
derived oligonucleosomes, but not with recombinant chromatin
(data not shown), raises the possibility that natural transcription-
ally active chromatins (with associated histone modifications)
may serve as preferential substrates for H2B ubiquitylation
in vitro. Our demonstration of a transcription requirement for
H2B ubiquitylation also provides a plausible explanation for
why H2B ubiquitylation-dependent H3K4 methylation marks
recent transcription (Ng et al., 2003b).
Strikingly, our transcription assays with a recombinant, fully
H2B-ubiquitylated chromatin template demonstrate that H2B
ubiquitylation per se has no demonstrable effect on the level of
hPAF complex- and SII-enhanced transcription mediated by
p53 in conjunction with p300. This contrasts with a previously
reported observation that hUbcH6-mediated H2B ubiquitylationCell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc. 469
directly stimulates FACT-dependent histone displacement and
transcription elongation in vitro (Pavri et al., 2006). Although we
failed to observe any effect of FACT, in the presence or absence
of RAD6-dependent H2B ubiquitylation, on the overall level of
transcription (data not shown), this may reflect in part the utiliza-
tion of NAP1, rather than FACT, as a histone chaperone in our
assays. Our results are consistent with those of Fleming et al.
(2008), who showed an in vivo role for H2B ubiquitylation in the
efficient reassembly of nucleosomes after Pol II passage,
thereby repressing cryptic transcription initiation, but found no
role in nucleosome disassembly during Pol II passage. Hence,
H2B ubiquitylation was proposed to function in the wake of
elongating Pol II rather than by directly stimulating Pol II elonga-
tion. Nontheless, and of note, our inability to see an effect of
robust H2B ubiquitylation on the overall level of transcription or
on transcription-related events may relate to our use of a defined
transcription system that lacks downstream factors that act in
conjunction with ubH2B (see below). Thus, our results overall
indicate that H2B ubiquitylation does not directly affect the
function of the transcriptional machinery, but that it is a conse-
quence of transcription that is important for events following
passage of Pol II.
Current observations suggest several possibilities for a posi-
tive role for H2B ubiquitylation in transcription-related events.
First, ubH2B may provide a binding platform for a factor(s) that
is responsible for downstream events such as histone modifica-
tion and chromatin remodeling during transcription elongation.
Second, and potentially related to the first possibility, H2B ubiq-
uitylation-dependent H3 methylation may affect transcription. In
this regard, H2B ubiquitylation was shown to directly stimulate
both hDOT1L-mediated H3K79 methylation (McGinty et al.,
2008) and hSET1 complex-mediated H3K4 di- and trimethylation
(Figure 6H). In relation to transcription, H3K4 trimethyl marks
are known to be recognized, for example, by PHD fingers in
factors affecting chromatin remodeling or histone modifications
(Ruthenburg et al., 2007). Third, H2B ubiquitylation, followed by
deubiquitylation, may also be required for promoter-proximal
transcription events on certain genes (Zhang et al., 2008), and
these requirements could be imposed by other unknown factors.
The defined transcription-H2B ubiquitylation system described
here should prove critical for a further characterization of




293T or HCT116 cells were treated with siRNA duplex (Dharmacon) using oli-
gofectamine according to the manufacturer’s instruction (GIBCO-Invitrogen).
Protein Interaction Assays
For GST-pull down assays, 4 mg of GST-fused proteins and 200 ng of purified
factors were mixed with glutathione-Sepharose 4B beads in binding buffer
(20 mM Tris-Cl [pH 7.9], 150 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.1%
NP-40, 0.5 mg/ml BSA, and 0.5 mM PMSF). For the interaction studies in
Figures 5C and 5E, M2 agarose preparations previously coupled with either
5 mg purified FLAG-hPAF complex or 2 mg purified FLAG-proteins were incu-
bated with 200 ng purified hBRE1 complex in the same binding buffer (except
for the inclusion of 300 mM KCl) as above. After 3 hr incubation at 4C, the
beads were washed and bound proteins were analyzed by immunoblots.470 Cell 137, 459–471, May 1, 2009 ª2009 Elsevier Inc.Coimmunoprecipitation assays were performed as described (Kim et al.,
2005).
In Vitro E3 Ubiquitylation Assays
Reactions containing 100 ng E1, 200 ng E2, 150 ng hBRE1 complex, 1.3 mg
His-pK-HA-ubiquitin that can be radiolabeled by protein kinase (Kim et al.,
2002; pK indicates protein kinase recognition site), 50 mM Tris-Cl (pH 7.9),
5 mMMgCl2, 2 mM NaF, 0.4 mM DTT, and 4 mM ATP in 20 ml were incubated
at 37C for 1 hr, resolved by SDS-PAGE, and subjected to autoradiography or
immunoblots.
In Vitro Chromatin Ubiquitylation Assays
Reactions containing the indicated amounts of HeLa cell-derived oligonucleo-
somes, hE1, E2, the hBRE1 complex, His-pK-HA-ubiquitin, 50 mM Tris-Cl
(pH 7.9), 5 mM MgCl2, 2 mM NaF, 0.4 mM DTT, and 4 mM ATP in 20 ml were
incubated at 37C for 10 hr, resolved by SDS-PAGE, and subjected to
immunoblotting.
In Vitro Chromatin Assembly, Transcription,
and Methyltransferase Assays
Procedures for ACF-mediated assembly of chromatin with recombinant
histone octamers were as described (An et al., 2004). Transcription assays
with the highly purified factors on chromatin templates were as described
(Guermah et al., 2006). For chromatin methyltransferase assays, reactions
containing 6 ml of purified hSET1 complex, 100 mM S-adenosylmethionine
(SAM), and 700 ng of recombinant chromatin (assembled as above except
for inclusion of 50 mM Tris-Cl [pH 8.5]) in 77 ml were incubated at 30C for
6 hr with addition of 1 ml of 7.5 mM SAM every 2 hr, resolved by SDS-PAGE,
and subjected to immunoblotting.
Chromatin Immunoprecipitation Assays
HCT116 cells grown in McCoy’s 5A (GIBCO-Invitrogen) were treated with
0.5 mM doxorubicin (Sigma) for the indicated times. ChIP analyses were per-
formed according to the manufacturer’s instruction (Upstate). Primers for
quantitative PCR were adopted from Donner et al. (2007) and are summarized
in Table S2.
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